Growth Metrics

Ultralife (ULBI) EPS (Weighted Average and Diluted) (2016 - 2025)

Ultralife (ULBI) has 15 years of EPS (Weighted Average and Diluted) data on record, last reported at -$0.07 in Q3 2025.

  • For Q3 2025, EPS (Weighted Average and Diluted) fell 450.0% year-over-year to -$0.07; the TTM value through Sep 2025 reached $0.01, down 97.78%, while the annual FY2024 figure was $0.38, 13.64% down from the prior year.
  • EPS (Weighted Average and Diluted) reached -$0.07 in Q3 2025 per ULBI's latest filing, down from $0.05 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $5.0 in Q2 2021 and bottomed at -$0.07 in Q3 2025.
  • Average EPS (Weighted Average and Diluted) over 4 years is $0.76, with a median of $0.08 recorded in 2024.
  • Peak YoY movement for EPS (Weighted Average and Diluted): surged 166.67% in 2024, then crashed 450.0% in 2025.
  • A 4-year view of EPS (Weighted Average and Diluted) shows it stood at $5.0 in 2021, then crashed by 96.6% to $0.17 in 2023, then plummeted by 94.12% to $0.01 in 2024, then tumbled by 800.0% to -$0.07 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Weighted Average and Diluted) were -$0.07 in Q3 2025, $0.05 in Q2 2025, and $0.02 in Q1 2025.